Application of MR-PET in Colorectal Cancer
- Conditions
- Colorectal Cancer
- Registration Number
- NCT02553031
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
This study will explore the potential value in proper therapeutic decision and clinical outcome prediction by using integrated MR-PET system and advanced MR techniques in patients with colorectal cancer.
- Detailed Description
This research expect that the image techniques and experience in this cancer group may be valuable and helpful for others. With advantage of MR-PET in better soft tissue delineation/functional information and less radiation dose than PET-CT, the ultimate goal in both research and clinical application is to establish new diagnostic standard and management guideline by MR-PET, which can further improve clinical outcome and disease prognosis in patients colorectal cancer.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Group 1: Patients with newly diagnosed colorectal cancers
- Group 2: Patients with suspicious recurrent colorectal cancers
Exclusion Criteria
- Age <20 or >90 years old
- Contraindication for MRI: claustrophobia or MR non-compatible devices
- Contraindication for MR contrast medium: severe adverse reaction or impaired renal function (Cre > 2.0)
- History of other malignancy
- Prior arthroplasty of hip (may cause artifacts on MRI)
- Pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The recurrence rate at 1 year after surgery 1 year
- Secondary Outcome Measures
Name Time Method The overall survival at 1 year after surgery 1 year
Trial Locations
- Locations (1)
National Taiwan University Hospital
🇨🇳Taipei, Taiwan